FTSE All-Share
4.998,68
PKT
+15,66
PKT
+0,31
%
Werbung
Analysen zu FTSE All-Share-Werten
Datum | Rating | Analyst | |
---|---|---|---|
14.12.12 | Mobico Group neutral | J.P. Morgan Cazenove | |
14.12.12 | AstraZeneca hold | Deutsche Bank AG | |
14.12.12 | HSBC buy | Deutsche Bank AG | |
14.12.12 | Centrica underperform | Exane-BNP Paribas SA | |
14.12.12 | SSE outperform | Exane-BNP Paribas SA | |
14.12.12 | Next underperform | Exane-BNP Paribas SA | |
14.12.12 | N.Brown Group underperform | Exane-BNP Paribas SA | |
14.12.12 | Barclays buy | Deutsche Bank AG | |
14.12.12 | Marks Spencer underperform | Exane-BNP Paribas SA | |
14.12.12 | BP outperform | Exane-BNP Paribas SA | |
14.12.12 | Wm Morrison Supermarkets buy | Sarasin Research | |
14.12.12 | Standard Chartered hold | Deutsche Bank AG | |
13.12.12 | Rio Tinto overweight | J.P. Morgan Cazenove | |
12.12.12 | Burberry neutral | Nomura | |
12.12.12 | BAE Systems buy | Deutsche Bank AG | |
12.12.12 | Unilever buy | UBS AG | |
12.12.12 | BP kaufen | Independent Research GmbH | |
12.12.12 | Unilever halten | Hamburger Sparkasse AG (Haspa) | |
12.12.12 | Serco Group equal-weight | Morgan Stanley | |
12.12.12 | GSK neutral | Credit Suisse Group | |
12.12.12 | Tullow Oil overweight | Morgan Stanley | |
12.12.12 | GSK hold | Deutsche Bank AG | |
12.12.12 | AstraZeneca underperform | Credit Suisse Group | |
12.12.12 | AstraZeneca hold | Deutsche Bank AG | |
12.12.12 | Diageo buy | Nomura | |
12.12.12 | Rio Tinto buy | Nomura | |
12.12.12 | Antofagasta neutral | Nomura | |
12.12.12 | Anglo American neutral | Nomura | |
12.12.12 | Tullow Oil outperform | Exane-BNP Paribas SA | |
12.12.12 | Vodafone Group overweight | HSBC | |
11.12.12 | Prudential buy | UBS AG | |
11.12.12 | BAT overweight | J.P. Morgan Cazenove | |
11.12.12 | Sky outperform | Exane-BNP Paribas SA | |
11.12.12 | GSK halten | Norddeutsche Landesbank (Nord/LB) | |
11.12.12 | Barclays buy | Citigroup Corp. | |
11.12.12 | Lloyds Banking Group buy | Citigroup Corp. | |
10.12.12 | Lloyds Banking Group outperform | Exane-BNP Paribas SA | |
10.12.12 | HSBC outperform | Exane-BNP Paribas SA | |
10.12.12 | Standard Chartered neutral | Exane-BNP Paribas SA | |
10.12.12 | HSBC buy | Citigroup Corp. |